nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice
|
Sun, Hong-Xiang |
|
2006 |
24 |
17 |
p. 3432-3439 8 p. |
artikel |
2 |
An effective cancer vaccine modality: Lentiviral modification of dendritic cells expressing multiple cancer-specific antigens
|
Wang, Bei |
|
2006 |
24 |
17 |
p. 3477-3489 13 p. |
artikel |
3 |
A nematode allergen elicits protection against challenge infection under specific conditions
|
Hartmann, Susanne |
|
2006 |
24 |
17 |
p. 3581-3590 10 p. |
artikel |
4 |
A non-invasive QPCR method monitoring DNA based therapy of bladder cancer patients
|
Ayesh, Suhail |
|
2006 |
24 |
17 |
p. 3420-3425 6 p. |
artikel |
5 |
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
|
Zhou, Zhimin |
|
2006 |
24 |
17 |
p. 3624-3631 8 p. |
artikel |
6 |
Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination
|
Perkins, Stuart D. |
|
2006 |
24 |
17 |
p. 3440-3445 6 p. |
artikel |
7 |
Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9)
|
Jagadish, Nirmala |
|
2006 |
24 |
17 |
p. 3695-3703 9 p. |
artikel |
8 |
Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits
|
Ribot, W.J. |
|
2006 |
24 |
17 |
p. 3469-3476 8 p. |
artikel |
9 |
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)
|
Goodman, Laura B. |
|
2006 |
24 |
17 |
p. 3636-3645 10 p. |
artikel |
10 |
Co-stimulatory agonists as immunological adjuvants
|
Barr, Tom A. |
|
2006 |
24 |
17 |
p. 3399-3407 9 p. |
artikel |
11 |
Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates
|
Mascarell, Laurent |
|
2006 |
24 |
17 |
p. 3490-3499 10 p. |
artikel |
12 |
Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production
|
Fingermann, M. |
|
2006 |
24 |
17 |
p. 3513-3521 9 p. |
artikel |
13 |
DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles
|
Horiuchi, Reii |
|
2006 |
24 |
17 |
p. 3677-3685 9 p. |
artikel |
14 |
Editorial Board/Aims and Scope
|
|
|
2006 |
24 |
17 |
p. CO2- 1 p. |
artikel |
15 |
Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000–2001 influenza season
|
Kamada, Makoto |
|
2006 |
24 |
17 |
p. 3618-3623 6 p. |
artikel |
16 |
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
|
Empig, Cyril |
|
2006 |
24 |
17 |
p. 3686-3694 9 p. |
artikel |
17 |
HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant
|
Patel, Jigna |
|
2006 |
24 |
17 |
p. 3564-3573 10 p. |
artikel |
18 |
Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model
|
Mawas, Fatme |
|
2006 |
24 |
17 |
p. 3505-3512 8 p. |
artikel |
19 |
Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum
|
Katare, Yogesh K. |
|
2006 |
24 |
17 |
p. 3599-3608 10 p. |
artikel |
20 |
Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults
|
Kulkarni, P.S. |
|
2006 |
24 |
17 |
p. 3457-3460 4 p. |
artikel |
21 |
Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette–Guèrin expressing malarial and tuberculosis epitopes
|
Rapeah, S. |
|
2006 |
24 |
17 |
p. 3646-3653 8 p. |
artikel |
22 |
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha
|
de Avila Botton, Sonia |
|
2006 |
24 |
17 |
p. 3446-3456 11 p. |
artikel |
23 |
Inadvertent rubella vaccination of pregnant women: Evaluation of possible transplacental infection with rubella vaccine
|
Hamkar, Rasool |
|
2006 |
24 |
17 |
p. 3558-3563 6 p. |
artikel |
24 |
Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination
|
Webster, D.E. |
|
2006 |
24 |
17 |
p. 3538-3544 7 p. |
artikel |
25 |
Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette–guerin in mice
|
Takahashi, Hiroki |
|
2006 |
24 |
17 |
p. 3591-3598 8 p. |
artikel |
26 |
Passive surveillance for generalized vaccinia in the United States using the Vaccine Adverse Event Reporting System (VAERS)
|
Bryant-Genevier, Marthe |
|
2006 |
24 |
17 |
p. 3632-3635 4 p. |
artikel |
27 |
Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series
|
Pittman, Phillip R. |
|
2006 |
24 |
17 |
p. 3654-3660 7 p. |
artikel |
28 |
Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses
|
Goter-Robinson, Carol |
|
2006 |
24 |
17 |
p. 3522-3529 8 p. |
artikel |
29 |
Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluation
|
De Wals, Philippe |
|
2006 |
24 |
17 |
p. 3500-3504 5 p. |
artikel |
30 |
Repeat JVAC 5730 from issue 24/13 and update pagination
|
|
|
2006 |
24 |
17 |
p. 3704- 1 p. |
artikel |
31 |
Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination
|
Guilloteau, Laurence A. |
|
2006 |
24 |
17 |
p. 3461-3468 8 p. |
artikel |
32 |
Starch microparticles as a vaccine adjuvant: Only uptake in Peyer's patches decides the profile of the immune response
|
Stertman, Linda |
|
2006 |
24 |
17 |
p. 3661-3668 8 p. |
artikel |
33 |
Stockpile levels for pediatric vaccines: How much is enough?
|
Jacobson, Sheldon H. |
|
2006 |
24 |
17 |
p. 3530-3537 8 p. |
artikel |
34 |
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate
|
Horimoto, Taisuke |
|
2006 |
24 |
17 |
p. 3669-3676 8 p. |
artikel |
35 |
The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs
|
Martin, Carlos |
|
2006 |
24 |
17 |
p. 3408-3419 12 p. |
artikel |
36 |
Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed
|
Rogers, James V. |
|
2006 |
24 |
17 |
p. 3609-3617 9 p. |
artikel |
37 |
Transience of vaccine-induced HIV-1-specific CTL and definition of vaccine “response”
|
Jamieson, Beth D. |
|
2006 |
24 |
17 |
p. 3426-3431 6 p. |
artikel |
38 |
Vaccination with polysaccharide-conjugate-vaccines in adult patients with specific antibody deficiency
|
Shrimpton, Anna |
|
2006 |
24 |
17 |
p. 3574-3580 7 p. |
artikel |
39 |
Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB
|
Pettersson, Annika |
|
2006 |
24 |
17 |
p. 3545-3557 13 p. |
artikel |